Singapore-based deep tech company expands European ambitions across AI data centres, PFAS detection, and mission-critical industrial sectors
SINGAPORE, June 30, 2026 /PRNewswire/ -- Aprisium Pte Ltd, a Singapore-based deep tech company specialising in real-time, autonomous contamination monitoring and backed by Cocoon Capital, is expanding in Europe with advanced solutions for mission-critical sectors including AI data centres, semiconductors, industrial water, and environmental compliance.
As Europe accelerates investment in AI infrastructure, data centres are facing increasing pressure to improve uptime, water efficiency, thermal reliability, and environmental performance. Aprisium's real-time monitoring solutions are designed to support this transition by delivering continuous intelligence across both primary and secondary cooling loops.
For AI data centres using direct liquid cooling (DLC), Aprisium provides real-time monitoring of primary loop water quality, currently aligned to ASHRAE Standard 188, and secondary loop DLC fluids, aligned to Open Compute Project (OCP) reference standards. By enabling faster detection of contamination, corrosion risk, fluid degradation, and operational anomalies, Aprisium helps operators protect high-value compute infrastructure while improving resilience, sustainability, and operating efficiency.
In addition to data centre applications, Aprisium is advancing rapid, on-site PFAS detection capabilities. The company's technology is being developed to detect PFAS speciated to individual molecules with a limit of quantification down to 1 ppt, currently in validation across key regulated PFAS compounds. This capability has the potential to reduce turnaround times from days to hours compared with conventional laboratory-based approaches, helping industries, regulators, and communities respond faster to one of the world's most urgent environmental contamination challenges.
Aprisium recently signed a Memorandum of Understanding with TÜVAUSTRIA Group during Singapore International Water Week, marking an important step toward building a complementary collaboration in real-time monitoring, laboratory services, validation, and certification. The MoU was signed by Adrian Lo, Executive Vice President, TÜVAUSTRIA Group / TÜV Austria Singapore Pte Ltd, and Raghav Narayan, CEO, Aprisium Pte Ltd.
Founded in 1872, TÜVAUSTRIA is an internationally recognised testing, inspection, and certification group with services across more than 40 countries. Through this collaboration, TÜVAUSTRIA's strong presence and credibility in Europe and the Middle East can support Aprisium's expansion into these strategic markets, including as a potential channel partner. Aprisium can, in turn, support TÜVAUSTRIA's clients in APAC with advanced laboratory services, real-time on-site monitoring, and faster turnaround solutions.
"This collaboration is about combining real-time intelligence with trusted validation. For sectors such as AI data centres, semiconductors, pharmaceuticals, and industrial wastewater, the ability to detect risk earlier, respond faster, and demonstrate compliance with confidence is becoming essential. Europe is a natural growth market for Aprisium, given its strong focus on sustainability, regulatory assurance, and high-reliability infrastructure."
— Raghav Narayan, CEO, Aprisium Pte Ltd
"Europe's rapid investment in AI infrastructure and environmental compliance is creating real demand for continuous monitoring. This collaboration with TÜVAUSTRIA gives Aprisium a credible route into these markets, and we are proud to back a Singapore deep tech company taking its technology onto the global stage."
— Michael Blakey, Managing Partner, Cocoon Capital
Aprisium's European expansion will focus on high-growth and mission-critical sectors, including AI data centres, PFAS monitoring, semiconductor manufacturing, pharmaceuticals, and industrial wastewater. The company aims to bring Singapore-developed deep tech solutions to customers seeking faster insights, stronger compliance, and more resilient operations.
About Aprisium
Aprisium Pte Ltd is a Singapore-based deep tech company delivering real-time, autonomous contamination monitoring solutions for water and fluid systems. Its technologies combine advanced sensing, IoT-enabled analysers, AI-powered analytics, and on-site intelligence to help industries detect contamination at source, optimise operations, reduce waste, and improve both sustainability and profitability.
View original content:https://www.prnewswire.co.uk/news-releases/aprisium-signs-mou-with-tuvaustria-to-advance-real-time-monitoring-in-europe-and-the-middle-east-302814267.html
Die Zahl der Demenzerkrankungen in Deutschland könnte bis 2060 deutlich ansteigen und das Versorgungssystem spürbar unter Druck setzen. Nach neuen Prognosen des Wissenschaftlichen Instituts der AOK (WIdO) dürfte die Zahl der Betroffenen bei weiter steigender Lebenserwartung von derzeit rund 1,3 Millionen auf bis zu 2,1 Millionen zunehmen. Grundlage der Berechnungen ist ein kleinräumiges Prognoseverfahren, das das Institut gemeinsam mit den Universitäten Trier, Rostock und Köln entwickelt hat.
Die Analyse reicht hinunter bis auf die Ebene von 400 Kreisen und kreisfreien Städten und macht deutliche regionale Unterschiede sichtbar. Bereits 2020 lag der Anteil der Demenzkranken zwischen 1,0 Prozent in Tübingen und 2,6 Prozent in der brandenburgischen Prignitz. Für das Jahr 2060 erwarten die Forscher eine Spanne von 1,7 Prozent Demenzkranken in München bis zu 6,2 Prozent im Landkreis Elbe-Elster in Brandenburg. Besonders betroffen sind damit vor allem ländliche Regionen im Osten, die überdurchschnittlich altern.
Parallel zur wachsenden Zahl von Demenzfällen schrumpft der Pool potenzieller Pflege- und Betreuungspersonen im Erwerbsalter. Laut Studie kamen im Jahr 2020 rechnerisch noch 38 Menschen im erwerbsfähigen Alter auf einen Demenzfall. Bis 2060 dürfte dieses Verhältnis auf 21 Erwerbspersonen pro Fall sinken. Damit würden deutlich mehr Erkrankte von einer deutlich kleineren Zahl potenziell Erwerbstätiger versorgt werden müssen – mit entsprechenden Konsequenzen für Pflegeinfrastruktur, Kommunen und Sozialversicherungen.
Die Autoren der Studie betonen zugleich, dass der prognostizierte Anstieg nicht zwangsläufig ist. Nach heutigem wissenschaftlichem Stand lassen sich Demenzrisiken durch Prävention spürbar senken. Eine konsequentere Behandlung von Bluthochdruck und Diabetes, der Verzicht auf Rauchen oder ein höheres Bildungsniveau könnten dazu beitragen, etwa die Hälfte der Neuerkrankungen zu vermeiden. In einem solchen Szenario würde sich die Zahl der Demenzfälle im Jahr 2060 nicht weiter erhöhen, sondern sich auf einem Niveau zwischen 1,3 und 1,5 Millionen stabilisieren. Die Spannbreite der Projektionen zeigt damit, wie stark der künftige Versorgungsdruck von heute eingeleiteten Präventionsstrategien abhängen dürfte.